Houlihan Lokey Q3 EPS Rises 18% to $1.94, Tops Estimates

HLIHLI

Houlihan Lokey reported Q3 fiscal 2026 earnings of $1.94 per share, beating the $1.85 Zacks Consensus Estimate and up from $1.64 a year ago. Quarterly revenues also topped analyst expectations, reflecting stronger deal activity in advisory services year-over-year.

1. Third-Quarter Earnings Surge

Houlihan Lokey reported third-quarter earnings of $1.94 per diluted share, a 18% increase from $1.64 in the year-ago quarter and ahead of the Zacks Consensus Estimate of $1.85. Net income rose to $125 million, up from $106 million a year earlier, driven by improved profitability in advisory fees and expense discipline. Operating margin expanded by 220 basis points to 28.4%.

2. Revenue and Deal-Flow Momentum

Total revenues for the quarter climbed 14% year-over-year to $765 million, outpacing the street estimate by 3%. Advisory fees increased 17% to $502 million, led by strong merger and acquisition advisory engagements in the technology and healthcare sectors. Restructuring and recapitalization fees contributed $128 million, marking a 12% gain as distressed activity remained elevated in select industries. Financial restructuring revenues rose 9%, bolstered by several high-profile mandates in retail and energy.

3. Strategic Investments and Talent Growth

The firm added 85 professionals globally during the quarter, bringing headcount to 2,280 and reinforcing its coverage in Europe and Asia-Pacific. Investments in technology, including a proprietary data analytics platform launched in November, have already generated six advisory mandates and are expected to double recurring subscription revenue by fiscal year-end. Infrastructure spending totaled $12 million in Q3, focusing on cybersecurity and remote-work capabilities.

4. Full-Year Outlook and Capital Return

Management reiterated its full-year guidance of $7.50 to $7.70 in earnings per share, implying 15% growth at the midpoint. Fee-earning transaction backlog stood at $1.9 billion as of January 28, up 8% from the prior quarter. The board approved a new $250 million share-repurchase program, complementing the quarterly dividend increase of 10% to $0.25 per share. The firm expects leverage to remain below 1.5x net debt to EBITDA through fiscal 2026.

Sources

ZSZ